FAM76B Inhibitors
FAM76B inhibitors encompass a range of chemical compounds that indirectly influence the activity of FAM76B by targeting various signaling pathways and cellular processes. For instance, kinase inhibitors such as staurosporine, U0126, SB203580, and PD98059 act on different kinases within the MAPK pathway, which is central to cellular responses to extracellular signals. Inhibition of these kinases can suppress the signaling cascades that potentially regulate FAM76B's activity, especially if it is involved in transcriptional regulation or other processes downstream of MAPK signaling. Similarly, PI3K inhibitors likeLY294002 and Wortmannin can attenuate the PI3K/AKT pathway, which may indirectly decrease the activity of FAM76B by impeding the signaling required for its function, particularly if FAM76B plays a role in survival and proliferation.
Chemicals such as SP600125, Y-27632, and Rapamycin target other diverse pathways that could be linked to the functional regulation of FAM76B. SP600125 inhibits the JNK pathway, which is involved in the regulation of apoptosis and inflammation, potentially reducing the demand for FAM76B's role in these cellular processes. The ROCK inhibitor Y-27632 affects cell shape and motility by modulating the Rho/ROCK pathway, which could indirectly result in diminished FAM76B activity if it is connected to these cellular mechanics. Rapamycin's inhibition of the mTOR pathway implicates a possible decrease in FAM76B activity related to growth and proliferation signals. Meanwhile, cell cycle and mitotic progression are critical points of regulation in which FAM76B might be involved. Agents such as roscovitine and ZM-447439, which inhibit CDKs and Aurora kinases respectively, could disrupt the cell cycle or mitotic events, leading to a downstream reduction in FAM76B activity if it is associated with these processes. Lastly, sunitinib, as a broad-spectrum receptor tyrosine kinase inhibitor, may impede multiple signaling pathways, including those regulating proliferation, potentially impacting FAM76B activity if it is active within these pathways.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is an inhibitor of protein kinases. It can inhibit a wide range of kinases by blocking their ATP binding sites. Since FAM76B is a protein that may be involved in transcriptional regulation, kinase activity is often crucial for initiating transcriptional events. Inhibition of specific kinases that propagate signals resulting in FAM76B activity can indirectly lead to its functional inhibition. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK, which is a part of the MAPK/ERK pathway. This pathway is implicated in a variety of cellular processes including growth and differentiation. FAM76B, if involved in processes regulated by this pathway, could be indirectly inhibited in its function due to decreased pathway signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAPK. The p38 MAPK pathway is involved in stress responses and apoptosis. If FAM76B functions are tied to these cellular responses, inhibition of p38 MAPK could indirectly decrease FAM76B activity by reducing the demand for its involvement in stress response pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. PI3K/AKT pathway is critical for cellular survival and growth signals. If FAM76B is involved downstream of this pathway, inhibiting PI3K can lead to reduced FAM76B activity by curtailing the survival and growth signaling that may be necessary for FAM76B's function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another potent PI3K inhibitor. By inhibiting PI3K, it can decrease AKT signaling, leading to reduced survival and proliferation signals. If FAM76B is functionally active in these contexts, wortmannin could indirectly inhibit FAM76B's activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a specific inhibitor of MEK, which blocks the activation of MAPK/ERK pathway. If FAM76B operates downstream of this signaling, its functional activity could be reduced due to the suppression of the necessary upstream signals. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which is part of the MAPK signaling pathway. By inhibiting JNK, it can impede the signaling that regulates various cellular processes, including inflammation and apoptosis, potentially decreasing FAM76B activity if it is involved in these processes. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor. The Rho/ROCK pathway influences cell shape, motility, and contraction. Inhibition of ROCK could result in decreased FAM76B activity if FAM76B is involved in cellular processes governed by this pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor. The mTOR pathway is involved in cell growth, proliferation, and survival. If FAM76B's function is related to these processes, rapamycin can indirectly inhibit its activity through mTOR pathway inhibition. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine is a cyclin-dependent kinase (CDK) inhibitor. CDKs are crucial for cell cycle regulation. If FAM76B is implicated in cell cycle-related processes, its activity could be indirectly inhibited by roscovitine through the inhibition of CDKs. | ||||||